FDA Clearance Tracker · P090015
BOND ORACLE HER2 IHC SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 18, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Apr 18, 2012
Approved
Time to decision
1,001 days
Received Jul 22, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P090015
- Device name
- BOND ORACLE HER2 IHC SYSTEM
- Applicant
- Leica Biosystems
- Applicant location
- Danvers, MA
- Received
- Jul 22, 2009
- Decided
- Apr 18, 2012
- Decision
- Approved
- Supplements
- 14 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- SYSTEM, TEST, HER-2/NEU, IHC (MVC)
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE BOND ORACLE HER2 IHC SYSTEM. THIS DEVICE IS INDICATED FOR: BOND ORACLE HER2 IHC SYSTEM IS A SEMI-QUANTITATIVE IMMUNOHISTOCHEMICAL (IHC) ASSAY TO DETERMINE HER2 (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) ONCOPROTEIN STATUS IN FORMALIN-FIXED, PARRAFIN EMBEDDED BREAST CANCER TISSUE PROCESSED FOR HISTOLOGICAL EVALUATION FOLLOWING AUTOMATED STAINING ON THE BOND-MAX SLIDE STAINING INSTRUMENT. THE BOND ORACLE HER2 IHC SYSTEM IS INDICATED AS AN AID IN THE ASSESSMENT OF PATIENTS FOR WHOM HERCEPTIN (TRASTUZUMAB) TREATMENT IS BEING CONSIDERED.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MVC. The earliest in FDA's data is P980018, decided Sep 25, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Leica Biosystems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253554 · Decided Aug 7, 2026 · 266 days after receipt
Device type: Whole Slide Imaging System (PSY) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.